HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

De novo heterozygous Hb G-Waimanalo (α64(E13)Asp>Asn, CTG>CCG; HBA1:c.193G>A) variant in a sickle cell disease patient of an Indian tribe.

AuthorsRavindra Kumar, Sweta Mishra, Ram Swaroop Uikey, Anil Gwal, Amol Mun, Praveen K Bharti, Rajasubramaniam Shanmugam
JournalJournal of clinical pathology (J Clin Pathol) Vol. 74 Issue 5 Pg. 336-338 (May 2021) ISSN: 1472-4146 [Electronic] England
PMID32817264 (Publication Type: Case Reports, Letter)
Chemical References
  • Genetic Markers
  • Hemoglobins, Abnormal
  • hemoglobin G Waimanalo
Topics
  • Anemia, Sickle Cell (diagnosis, genetics)
  • Child
  • Female
  • Genetic Markers
  • Genetic Testing
  • Hemoglobins, Abnormal (genetics)
  • Heterozygote
  • Humans
  • India
  • Indigenous Peoples (genetics)
  • Mutation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: